
All G Announces Self-Affirmed GRAS Status for Recombinant Human Lactoferrin
Key Takeaways
- All G’s recombinant human lactoferrin targets adult nutrition/supplements with self-affirmed GRAS, while positioning as breast milk–like via sequence identity, low iron saturation, and prevalent variant inclusion.
- Functional rationale centers on lactoferrin’s roles in iron homeostasis, innate immune defense, and gut health, with cited support for receptor recognition and simulated-digestion peptide-release similarity.
The company says the ingredient is intended for adult nutrition and supplement applications, with further trials underway.
All G on November 18 announced that it has self-affirmed generally recognized as safe (GRAS) status for its recombinant human lactoferrin in adult nutrition and supplement applications, according to a company press release.1 The Sydney-based biotechnology company describes the ingredient as designed to match the lactoferrin found in breast milk.
What Does All G Say Sets Human Lactoferrin Apart?
According to the company, lactoferrin is among the most abundant bioactive proteins in breast milk and is associated with iron regulation, immune defense, and gut health.2 Studies cited in All G’s press release describe 4 attributes of human lactoferrin: it is not a cow’s milk allergen,3 it is recognized by the small intestinal lactoferrin receptor,4 it has showed a peptide-release profile similar to that of breast milk lactoferrin in simulated adult digestion, according to a study of a different recombinant human lactoferrin,5 and it was met with high acceptance in a small focus-group study of infant formula carers.6
How Closely Does It Match Breast Milk Lactoferrin?
All G reported that 94% of women carry a lactoferrin variant with a cluster of 4 amino acids that supports binding to bacteria and human cells. Jared Raynes, All G’s chief scientific officer, said, “Think of a rowboat with 4 people. Lose one rower and the boat still moves, but pulls off balance and loses drive.”
The company’s protein has all 4 and, like breast milk lactoferrin, is produced with low iron saturation. All G stated that no other GRAS human lactoferrin matches breast milk lactoferrin on both counts.
The release does not state whether the GRAS determination has been submitted to the US Food and Drug Administration.
What Did In-House Testing Show?
All G reported side-by-side comparisons against a currently available commercial human lactoferrin, which the release does not name. The company’s protein showed 2.2 times the antimicrobial potency against E. coli strain W3110, 1.3 times stronger heparin binding, and 2.3 times higher iron-binding capacity. All G said further trials are underway; the release does not describe their design or state whether the comparison data have been published.
What Does the Company Website Add?
All G’s product page describes the ingredient as having an amino acid sequence identical to native human lactoferrin and as supplied predominantly in the iron-free (apo) form, which the page says enables active iron binding.7 It also claims higher retention of intact protein during digestion and describes the protein as hypoallergenic. The bioactivity and digestion claims are attributed to heparin-binding assays, INFOGEST digestion testing, and sequence homology screening, but the page does not report the data.
How Does It Fit With All G’s Existing Product?
Human lactoferrin follows LFX bovine lactoferrin, which All G launched earlier in 2026. The company says it is now the only one with both forms in market. All G said human lactoferrin is drawing interest in women’s health and childhood applications, while bovine lactoferrin has demonstrated benefits for immunity and gut health.
What Are Future Plans for All G?
All G said it has already developed recombinant micellar human caseins and is developing human alpha-lactalbumin and other human milk proteins, a pipeline it says would allow an infant formula built entirely from human milk proteins.
Jan Pacas, All G’s CEO, said, “Human lactoferrin is the first of many human milk proteins we will bring to market. We are leading the world in replicating the protein profile of human breast milk.”
References
- All G. All G self-affirms world-first GRAS for human lactoferrin in most complete and bioactive form. Press release. November 18, 2026. Accessed November 17, 2026.
- Telang S. Lactoferrin: a critical player in neonatal host defense. Nutrients. 2018;10(9):1228. doi:10.3390/nu10091228
- Gaudin JC, Rabesona H, Choiset Y, et al. Assessment of the immunoglobulin E-mediated immune response to milk-specific proteins in allergic patients using microarrays. Clin Exp Allergy. 2008;38(4):686-693. doi:10.1111/j.1365-2222.2008.02952.x
- Suzuki YA, Lopez V, Lönnerdal B. Mammalian lactoferrin receptors: structure and function. Cell Mol Life Sci. 2005;62(22):2560-2575. doi:10.1007/s00018-005-5371-1
- Kim BJ, Kuhfeld RF, Haas JL, Dallas DC. Digestive profiles of human milk, recombinant human and bovine lactoferrin: comparing the retained intact protein and peptide release. Nutrients. 2024;16(14):2360. doi:10.3390/nu16142360
- Mankad A, Carter L. Primary carers’ readiness for human lactoferrin in infant formula using precision fermentation. Future Foods. 2025;11:100526. doi:10.1016/j.fufo.2024.100526
- All G. Human lactoferrin. All G website. Accessed November 17, 2026.
https://www.allg.com/human-lactoferrin/
Related to this article








